FDA Approves Nasacort For Over-the-Counter Use

The Food and Drug Administration Oct. 11 approved Nasacort Allergy 24HR (triamcinolone acetonide), a nasal spray for the nonprescription or over-the-counter (OTC) treatment of nasal allergy symptoms.

Nasacort Allergy 24HR is labeled for use in children two years of age and older, adolescents and adults, the agency said. It is marketed by Bridgewater, N.J.-based Sanofi-aventis U.S. Inc.

Nasacort Allergy 24HR belongs to a class of drugs known as glucocorticoids, the FDA said. It is the first drug in this class to be made available OTC for treating the symptoms of nasal allergies.

The product initially was approved as a prescription-only ...